
Jennifer E. Graser
Examiner (ID: 4480, Phone: (571)272-0858 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1802, 1621, 1641, 1645 |
| Total Applications | 1928 |
| Issued Applications | 1284 |
| Pending Applications | 235 |
| Abandoned Applications | 466 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19447405
[patent_doc_number] => 20240307535
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => ANTI-LAM AND ANTI-PIM6/LAM MONOCLONAL ANTIBODIES FOR DIAGNOSIS AND TREATMENT OF MYCOBACTERIUM TUBERCULOSIS INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 18/335489
[patent_app_country] => US
[patent_app_date] => 2023-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31031
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18335489
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/335489 | Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment of | Jun 14, 2023 | Issued |
Array
(
[id] => 18985643
[patent_doc_number] => 20240057612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => Combinations of Yersinia Entomophaga and Pesticides or Other Substances
[patent_app_type] => utility
[patent_app_number] => 18/331298
[patent_app_country] => US
[patent_app_date] => 2023-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56589
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18331298
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/331298 | Combinations of | Jun 7, 2023 | Issued |
Array
(
[id] => 18829673
[patent_doc_number] => 20230398197
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-14
[patent_title] => COLDWATER DISEASE VACCINE COMPRISING AN ATTENUATED FLAVOBACTERIUM PSYCHROPHILUM STRAIN
[patent_app_type] => utility
[patent_app_number] => 18/329816
[patent_app_country] => US
[patent_app_date] => 2023-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10869
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18329816
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/329816 | COLDWATER DISEASE VACCINE COMPRISING AN ATTENUATED FLAVOBACTERIUM PSYCHROPHILUM STRAIN | Jun 5, 2023 | Pending |
Array
(
[id] => 19792197
[patent_doc_number] => 12233120
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-25
[patent_title] => Proteins and immunizing compositions containing
[patent_app_type] => utility
[patent_app_number] => 18/203917
[patent_app_country] => US
[patent_app_date] => 2023-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 26797
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18203917
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/203917 | Proteins and immunizing compositions containing | May 30, 2023 | Issued |
Array
(
[id] => 18610908
[patent_doc_number] => 20230277638
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => SOUTHERN CATTLE TICK VACCINE PRODUCT
[patent_app_type] => utility
[patent_app_number] => 18/318909
[patent_app_country] => US
[patent_app_date] => 2023-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12669
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18318909
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/318909 | Southern cattle tick vaccine product | May 16, 2023 | Issued |
Array
(
[id] => 19096460
[patent_doc_number] => 20240115687
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => Attenuating bacterial virulence by attenuating bacterial folate transport
[patent_app_type] => utility
[patent_app_number] => 18/316499
[patent_app_country] => US
[patent_app_date] => 2023-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15830
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18316499
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/316499 | Attenuating bacterial virulence by attenuating bacterial folate transport | May 11, 2023 | Issued |
Array
(
[id] => 18724357
[patent_doc_number] => 20230338499
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => POLYPEPTIDES OF FUSOBACTERIUM AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 18/144568
[patent_app_country] => US
[patent_app_date] => 2023-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31642
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18144568
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/144568 | Polypeptides of fusobacterium and methods of use | May 7, 2023 | Issued |
Array
(
[id] => 19098194
[patent_doc_number] => 20240117422
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => MUTANT PORE
[patent_app_type] => utility
[patent_app_number] => 18/313079
[patent_app_country] => US
[patent_app_date] => 2023-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58943
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18313079
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/313079 | MUTANT PORE | May 4, 2023 | Pending |
Array
(
[id] => 18707624
[patent_doc_number] => 20230330201
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => COMPOSITIONS FOR USE AS A PROPHYLACTIC AGENT TO THOSE AT RISK OF INFECTION OF TUBERCULOSIS, OR AS SECONDARY AGENTS FOR TREATING INFECTED TUBERCULOSIS PATIENTS
[patent_app_type] => utility
[patent_app_number] => 18/309555
[patent_app_country] => US
[patent_app_date] => 2023-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11199
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18309555
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/309555 | COMPOSITIONS FOR USE AS A PROPHYLACTIC AGENT TO THOSE AT RISK OF INFECTION OF TUBERCULOSIS, OR AS SECONDARY AGENTS FOR TREATING INFECTED TUBERCULOSIS PATIENTS | Apr 27, 2023 | Abandoned |
Array
(
[id] => 18673049
[patent_doc_number] => 20230310521
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => COMBINATION COMPRISING BACILLUS AND AN ESSENTIAL OIL AND METHODS FOR MAKING AND USING
[patent_app_type] => utility
[patent_app_number] => 18/191328
[patent_app_country] => US
[patent_app_date] => 2023-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26386
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18191328
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/191328 | COMBINATION COMPRISING BACILLUS AND AN ESSENTIAL OIL AND METHODS FOR MAKING AND USING | Mar 27, 2023 | Abandoned |
Array
(
[id] => 18610914
[patent_doc_number] => 20230277644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => COMPOSITIONS COMPRISING STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE-PROTEIN CONJUGATES AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/188987
[patent_app_country] => US
[patent_app_date] => 2023-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53361
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18188987
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/188987 | COMPOSITIONS COMPRISING STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE-PROTEIN CONJUGATES AND METHODS OF USE THEREOF | Mar 22, 2023 | Abandoned |
Array
(
[id] => 19256885
[patent_doc_number] => 12016914
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-25
[patent_title] => Compositions comprising
[patent_app_type] => utility
[patent_app_number] => 18/188969
[patent_app_country] => US
[patent_app_date] => 2023-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 53413
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18188969
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/188969 | Compositions comprising | Mar 22, 2023 | Issued |
Array
(
[id] => 18649890
[patent_doc_number] => 20230295715
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => MUTANT PORES
[patent_app_type] => utility
[patent_app_number] => 18/159718
[patent_app_country] => US
[patent_app_date] => 2023-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58819
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18159718
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/159718 | Mutant pores | Jan 25, 2023 | Issued |
Array
(
[id] => 18649890
[patent_doc_number] => 20230295715
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => MUTANT PORES
[patent_app_type] => utility
[patent_app_number] => 18/159718
[patent_app_country] => US
[patent_app_date] => 2023-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58819
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18159718
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/159718 | Mutant pores | Jan 25, 2023 | Issued |
Array
(
[id] => 18374441
[patent_doc_number] => 20230149520
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => LONG LASTING EFFECT OF NEW BOTULINUM TOXIN FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 18/155301
[patent_app_country] => US
[patent_app_date] => 2023-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14615
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18155301
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/155301 | Long lasting effect of new botulinum toxin formulations | Jan 16, 2023 | Issued |
Array
(
[id] => 18647878
[patent_doc_number] => 20230293654
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => VACCINE FOR FALCIPARUM MALARIA
[patent_app_type] => utility
[patent_app_number] => 18/154642
[patent_app_country] => US
[patent_app_date] => 2023-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25067
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18154642
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/154642 | Vaccine for falciparum malaria | Jan 12, 2023 | Issued |
Array
(
[id] => 18364441
[patent_doc_number] => 20230146032
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => BURKHOLDERIA PSEUDOMALLEI COMPLEX OUTER MEMBRANE VESICLES AS ADJUVANTS
[patent_app_type] => utility
[patent_app_number] => 18/088690
[patent_app_country] => US
[patent_app_date] => 2022-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17909
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18088690
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/088690 | Burkholderia pseudomallei complex outer membrane vesicles as adjuvants | Dec 25, 2022 | Issued |
Array
(
[id] => 18320707
[patent_doc_number] => 20230118835
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => METHOD OF PRODUCING STREPTOCOCCUS THERMOPHILUS MUTANT STRAINS
[patent_app_type] => utility
[patent_app_number] => 18/145411
[patent_app_country] => US
[patent_app_date] => 2022-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9160
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18145411
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/145411 | Method of producing Streptococcus thermophilus mutant strains | Dec 21, 2022 | Issued |
Array
(
[id] => 19423759
[patent_doc_number] => 12083150
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-10
[patent_title] => Microbiota restoration therapy (MRT), composition and methods of manufacture
[patent_app_type] => utility
[patent_app_number] => 18/062934
[patent_app_country] => US
[patent_app_date] => 2022-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 19243
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18062934
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/062934 | Microbiota restoration therapy (MRT), composition and methods of manufacture | Dec 6, 2022 | Issued |
Array
(
[id] => 18737999
[patent_doc_number] => 20230346903
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => GROUP B STREPTOCOCCUS POLYSACCHARIDE-PROTEIN CONJUGATES, METHODS FOR PRODUCING CONJUGATES, IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATES, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/060779
[patent_app_country] => US
[patent_app_date] => 2022-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47498
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18060779
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/060779 | GROUP B STREPTOCOCCUS POLYSACCHARIDE-PROTEIN CONJUGATES, METHODS FOR PRODUCING CONJUGATES, IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATES, AND USES THEREOF | Nov 30, 2022 | Pending |